Description
R-10 represents an advanced synthetic peptide engineered as a triple agonist with activity at glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors. This multi-target approach allows for investigation of complex metabolic signaling networks and their integrated effects on glucose homeostasis, energy expenditure, and metabolic regulation. The compound incorporates structural modifications designed to achieve balanced activity across all three receptor systems while maintaining stability and bioavailability for research applications.
For research use only.
Reviews
There are no reviews yet.